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Sickness behaviorThe objective of this study was to ﬁnd out if lipopolysaccharide (LPS) administered intraperitoneally affects
sodium and water intake and renal excretion in dehydrated rats. LPS (0.3–5 mg/kg b.w.) inhibited 0.3 M NaCl
intake induced by subcutaneous injection of the diuretic furosemide (FURO, 10 mg/kg b.w.) combined with
the angiotensin converting enzyme inhibitor, captopril (CAP, 5 mg/kg b.w.). Only the highest doses of LPS (2.5
and 5 mg/kg) inhibited water intake induced by FURO/CAP. LPS (0.6 mg/kg) reduced urinary volume and
sodium excretion, but had no effect on mean arterial pressure or heart rate of rats treated with FURO/CAP. LPS
(0.3–5.0 mg/kg) abolished intracellular thirst and reduced by 50% the urine sodium concentration of rats that
received 2 ml of 2 M NaCl by gavage. LPS (0.3–5.0 mg/kg) also reduced thirst in rats treated with FURO alone
(10 mg/rat sc). The results suggest that LPS has a preferential, but not exclusive, inhibitory effect on sodium
intake and on intracellular thirst. The inhibition of hydro-mineral intake and the antinatriuresis caused by LPS
in dehydrated rats may contribute to themultiple effects of the endotoxin on ﬂuid and electrolyte balance and
be part of the strategy to cope with infections.y and Pathology, School of
versity - UNESP, 14801-903,
fax: +55 16 3301 6488.
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“Sickness behavior” has been hypothesized as to be an adaptive
syndrome of behavioral and physiological alterations of animals
coping with infectious pathogens [1]. Reduced activity, feeding and
drinking are some of the behavioral alterations induced by infection.
Lipopolysaccharide (LPS), an endotoxin derived from the wall of
gram-negative bacteria, triggers not only a general reduction in
animal activity, but also has a broad inﬂuence on body ﬂuid balance,
linked to neurohypophyseal secretion, sodium transport in the gut
and renal sodium excretion [2–5]. Although the sickness behavior
may have an adaptive value, reduced thirst, associated with impaired
sodium balance and dehydration, plus concurrent hypotension, may
lead to a general collapse of volume compartments in response to LPS
[6–9]. Therefore, a complete understanding of the effects of LPS on
ﬂuid balance has important practical and theoretical consequences.
The antidipsogenesis induced by LPS in a water-deprived rat has
been known for several years and it is mediated by central production
of nitric oxide, prostaglandins and, perhaps, TNF-α [10–12]. Thirst in a
water-deprived animal arises from double dehydration, a mechanismwhich comprises volume reduction in both intracellular and extra-
cellular compartments and is mediated by a combination of
osmorreception and angiotensin II [13,14]. Since LPS also inhibits
thirst induced by intracerebroventricular (icv) injections of either
angiotensin II or hypertonic NaCl [15] the effect of LPS on water intake
seems an outcome of inhibition of both mechanisms.
However, interleukin-1β, which belongs to a network of cytokines
activated by LPS [1], may selectively inhibit one type of thirst when it
is produced by systemic maneuvers that produce selective dehydra-
tion on body ﬂuid compartments. Interleukin-1β injected intraper-
itoneally inhibits intracellular thirst induced by intraperitoneal
injection of hypertonic NaCl, but has no effect on extracellular thirst
induced by subcutaneous injection of polyethylene glycol [16].
It is therefore reasonable to ask if LPS exerts a similarly selective
inhibition on thirst. A selective effect on ﬂuid intake may have
important implications for the overall strategy of the sickness
behavior. For example, the selective inhibition on intracellular thirst
could beneﬁt survival by maintaining blood hypertonicity and thus
increasing cardiovascular performance in response to endotoxemia
induced by LPS [16]. This suggests that LPS may have no effect on
sodium intake.
LPS also has inﬂuences on renal sodium excretion that may affect
ﬂuid intake. For example, septicaemia induces renal failure and
increased fractional sodium excretion associated with reduction in
tubular sodium transporter activity [5]. However, to the best of our
knowledge, it is not known whether LPS alters the sodium excretion
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intake.
Diuretics and sodium load are used in procedures to induce
extracellular and intracellular thirst respectively. The diuretic furose-
mide induces water intake acutely in response to extracellular
dehydration when sodium appetite is still incipient [17–19] and
gavage of hypertonic NaCl leads to water intake in response to
intracellular dehydration [20,21]. One advantage to give a hypertonic
load through intragastric route, compared to intraperitoneal or
subcutaneous [22], is to avoid pain.
Procedures to induce extracellular dehydration may lead not only
to water but also to sodium intake, but they require either a delay of
several hours or a strong initial stimulus. Rapid hypertonic NaCl and
water intake can be elicited in a two-bottle test by treating rats with a
systemic injection of furosemide combined with captopril, an
inhibitor of the angiotensin-converting enzyme (FURO/CAP). These
effects of FURO/CAP can be explained by assuming that while
furosemide induces fast, heavy extracellular dehydration – a powerful
stimulus for secretion of renin which converts angiotensinogen to
angiotensin I – captopril given at a low dose prevents the formation of
circulating angiotensin II. The reduced conversion to angiotensin II
may thus increase the delivery of angiotensin I to encephalic areas not
reached by captopril [14,18,23–25]. Angiotensin I is then converted to
angiotensin II in the brain and thus newly formed angiotensin II,
accompanied by mild hypotension, triggers the circuits subserving
sodium and water intake.
The objective of the present work was to ﬁnd out, ﬁrst, whether
LPS inhibits the sodium and water intake induced by FURO/CAP and,
second, whether it has a preferential effect on extracellular, as
opposed to intracellular dehydration. Effects of LPS on the renal
sodium excretion associated with each treatment were also
investigated.
2. Methods
2.1. Animals
Male Holtzman rats weighing 280–320 g were used. The animals
were housed in individual stainless steel cages with free access to
standard laboratory chow (0.5–1.0%, Guabi Rat Chow, Paulínia, São
Paulo, Brazil) with more sodium than the rat requires [26], water and
0.3 M NaCl solution. Rats were maintained in a room whose
temperature was controlled at 23±2 °C and humidity at in a 12 h
light/dark cycle lights on 7:30 AM. The experimental protocols were
approved by the Institutional Ethical Committee for Animal Care and
Use (CEEA) and followed the recommendations of the Brazilian
College of Animal Experimentation (COBEA).
2.2. Drugs
Lipopolysaccharide extracted from Escherichia coli, serotype 026:
B6 (Sigma), was dissolved in sterile isotonic saline at doses of 0.15–
5 mg/kg b.w.
Furosemide (diuretic) (Sigma) was dissolved in isotonic saline,
adjusted to pH=9.0 with 0.1 N sodium hydroxide solution at a dose
of 10 mg/kg b.w. (FURO/CAP) or 10 mg/rat (furosemide-induced
thirst).
Captopril (angiotensin converting enzyme inhibitor) (Sigma) was
dissolved in sterile isotonic saline at a dose of 5 mg/kg b.w.
2.3. Body temperature measurement
Rectal temperature was measured by digital thermometer imme-
diately before LPS injection and at the intervals described in the
experiments with FURO/CAP.2.4. Urine sample collection
The animals were housed in metabolic cages at the beginning of
the test and the urine spontaneously eliminated was collected every
60 min for 2 h. Urine sodium and potassium concentrations were
measured with an ion sensitive electrode (Nova 1, Nova Biomedical).
2.5. Blood biochemistry
Immediately after decapitation, trunk blood samples were collect-
ed in tubes containing a separating gel and serum was separated by
centrifugation (2000 rpm for 10 min). The sodium and potassium
serum concentrations were measured by ion sensitive electrode. Total
plasma protein concentration was measured by refractometry
(Atago).
2.6. Blood pressure and heart rate
In rats anaesthetized with ketamine (80 mg/kg b.w.) combined
with xylazine (7 mg/kg b.w.), a polyethylene tube (PE-10 connected
to a PE-50) was inserted into the abdominal aorta through the femoral
artery to record arterial pressure. An arterial catheter was tunneled
subcutaneously and exposed on the back of the rat. On the next day,
pulsatile arterial pressure, mean arterial pressure (MAP), and heart
rate (HR) were simultaneously recorded in unanaesthetized and
unrestrained rats by connecting the arterial catheter to a Statham
Gould (P23Db) pressure transducer coupled to a pre-ampliﬁer (model
ETH-200 Bridge Bio Ampliﬁer, CB Sciences, Dover, NH, USA) that was
connected to a PowerLab computer data acquisition system (model
Powerlab 16SP, ADInstruments, Castle Hill, Australia).
2.7. Intragastric (ig) hypertonic NaCl load (NaCl gavage)
The animals were removed from their cages and gently trained to
receive an ig load by infusing distilled water (1 ml) through a
polypropylene tubing (PE-10) connected to a syringe. The length of
the tubing and the effective sodium load (2 ml of 2 M NaCl) needed to
induce strong hypernatremia, natriuresis, reduced plasma renin
activity and thirst were based on previous work [21]. The training
began after 2 days of adaptation and was prescribed for once a day for
5 days. On the 6th day, each animal received an ig load of hypertonic
saline after food and every ﬂuid was removed from the cage. Water
was offered 1 h after gavage, for the drinking test.
2.8. Statistics
Two-way repeated measures ANOVA was used to analyze data
from the ingestive and arterial pressure tests with treatment and time
as factors. Planned comparisons were made with the Student-
Newman-Keuls post-hoc test. The unpaired t-test was used to analyze
data in the blood biochemistry and renal excretion tests. A probability
of less than 0.05 was required for signiﬁcance. Data are expressed as
means±standard error of the mean.
2.9. Effect of LPS on 0.3 M NaCl and water intake induced by a combined
injection of furosemide and captopril (FURO/CAP)
The animals (n=49) were gently manipulated to measure rectal
temperature once a day, by habituation, on the days that preceded a
FURO/CAP test. On the day of the test, food and ﬂuids were removed
and the animals randomly received an intraperitoneal injection of LPS
(0.15, 0.3, 0.6, 1.2, 2.5 or 5.0 mg/kg) or saline. One hour later, all
animals received simultaneous subcutaneous injections of the
natriuretic and diuretic furosemide, FURO (10 mg/kg), and a low
dose of the angiotensin-converting enzyme (ACE) inhibitor captopril,
CAP (5 mg/kg). Water and 0.3 M NaCl were offered from graduated
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the FURO/CAP injection. Water and 0.3 M NaCl intake was then
recorded at 15, 30, 60, 120, 180, 240 and 300 min. Rectal body
temperature was measured immediately before injecting LPS, before
offering water and 0.3 M NaCl, and at 120 and 300 min, after ﬂuid
intake recordings.
2.10. Effect of LPS on the hypotension induced by FURO/CAP
A group of animals (n=14) received an intra-arterial catheter by
surgery, as described above. Immediately after recovery from the
surgery the rats were moved to individual polypropylene cages with
wood-chip bedding, and given free access to food and water for 24 h,
after which they were transferred to the cardiovascular recording
room. After half an hour in this room, food and water were removed
and the catheter connected to the pressure transducer, while the
animal remained in its cage. Basal MAP and HR were recorded for
10 min. Next, half the group received 0.6 mg/kg of LPS ip and the other
half a control injection of saline. The cardiovascular recordings
proceeded without interruption for another 60 min, when each
animal received a FURO/CAP injection and the recordings persisted
for a ﬁnal 90 min.
2.11. Effects of LPS on urine excretion and blood biochemistry in rats
treated with FURO/CAP
A group of animals (n=15) was transferred to individual
metabolic cages, without access of food or ﬂuid. They were subdivided
into two groups, one that received 0.6 mg/kg LPS ip and another that
received saline. One hour later, all animals received a suprapubic
massage to induce urine void; urine collected during this ﬁrst hour
was discarded. Next, all animals received a FURO/CAP treatment and
urine was collected for another hour, to measure sodium and
potassium concentration. All animals received a ﬁnal suprapubic
massage to induce urine void, and were transferred to another room
for immediate blood collection. Trunk blood was collected as
described above, for biochemical analysis.
2.12. Effect of LPS on thirst induced by acute treatment with furosemide
or by gavage with 2 M NaCl
Furosemide alone induces massive natriuresis (about 1.5–2.0 mEq
in 1 h) and diuresis, followed by thirst within two hours [17,19,25].
On the day of the test, food and ﬂuids were removed and the animals
(n=35) randomly received an intraperitoneal injection of LPS (0.3,
0.6, 1.25 and 5.0 mg/kg) or saline. One hour later, all animals received
a subcutaneous injection of the natriuretic and diuretic furosemide
(10 mg/rat). Water was offered from graduated burettes (0.1 ml
division) ﬁtted with stainless steel spouts, 1 h after the furosemide
injection. Water intake was then recorded at 15, 30, 60, 120 and
180 min.
Animals in another group (n=33) were trained for the gavage
test. On the day of the test, food and ﬂuids were removed and the
animals randomly received an intraperitoneal injection of LPS (0.3,
0.6, 1.25 and 5.0 mg/kg mg/kg) or saline. One hour later, all animals
received 2 ml of 2 M NaCl by gavage, which induces hypernatremia
and hyperosmolality, with no signs of hypovolemia, within 1 h [21].
Water was offered from graduated burettes (0.1 ml division) ﬁtted
with stainless steel spouts, 1 h after the gavage. Water intake was
then recorded at 15, 30, 60, 120 and 180 min.
2.13. Effects of LPS on sodium excretion and blood biochemistry after 2 M
NaCl gavage
One group of animals (n=13) was transferred to individual
metabolic cages, without access to food or ﬂuid. Theywere subdividedinto two groups, one that received 1.0 mg/kg LPS ip and another that
received saline. One hour later all animals received a suprapubic
massage to induce urine void; urine collected during this ﬁrst hour
was discarded. Next, all animals received 2 M NaCl by gavage and
urine was collected for another hour to measure sodium and
potassium concentrations. All animals then received a last suprapubic
massage for urine void and trunk blood was immediately collected, as
described, for biochemical analysis.
3. Results
3.1. Effect of LPS on 0.3 M NaCl and water intake induced by FURO/CAP
There was a difference between treatments for the non-cumulative
0.3 M NaCl intake induced by FURO/CAP [F (6, 36)=4.0; p=0.003]
(Fig. 1, left). All (0.3–5 mg kg) but the smallest dose (0.15 mg/kg) of LPS
inhibited the 0.3 M NaCl intake compared to saline at 15 min. There
were no differences in time [F (4, 24)=1.9, p=0.135]. There was no
interaction between treatment and time [F (24, 144)=1.2, p=0.203].
Therewas a difference between treatments for the non-cumulative
water intake induced by FURO/CAP [F (6, 36)=3.6; p=0.006] (Fig. 1,
right). Only the highest doses of LPS (2.5 and 5 mg/kg) reduced the
water intake from 80 to 100% compared to saline at 15 min. There was
an effect for time [F (4, 24)=8.5, pb0.001]. There were no interaction
between treatment and time [F (24, 144)=1.5; p=0.062].
There was a difference between treatments for rectal tempera-
ture [F (6, 36)=3.9; p=0.045]. LPS (2.5 and 5 mg/kg) produced a
drop in rectal temperature (35.2±0.1 and 34.4±0.3 °C, respec-
tively) compared to saline (36.6±0.1 °C) at time zero, coinciding
with the beginning of the ingestive test. There was effect for time
[F (3, 18)=10.6; pb0.001]. Therewasaneffect for interactionbetween
treatment and time [F (18, 108)=2.3; p=0.004)].
The 2.5 or 5 mg/kg LPS also produced behavioral effects charac-
terized by piloerection and the body curled with the nostrils pointing
ventrally. No grooming was observed when the animals received
these two doses.
3.2. Effects of LPS on the hypotension induced by FURO/CAP
The dose of 0.6 mg/kg was chosen for this test because it
effectively suppressed sodium intake but did not produce hypother-
mia or alterations in posture.
With respect to MAP there was no signiﬁcant difference between
treatments (LPS 0.6 mg/kg vs saline) [F (1, 5)=0.1; p=0.758] (Fig. 2,
top). There was a signiﬁcant effect [F (14, 70)=4.6; pb0.001] for
variations of mean arterial pressure with time. There was no effect for
interaction between time and treatment [F (14, 70)=0.2; p=0.998].
There was also no signiﬁcant difference between treatments in heart
rate [F (1, 5)=0.8; p=0.403], but there was a signiﬁcant change over
time [F (14, 70)=5.4; pb0.001] and an interaction between time and
treatment [F (14, 70)=2.1; p=0.018] (Fig. 2, bottom).
3.3. Effects of LPS on thirst induced by acute treatment with furosemide
or 2 M NaCl gavage
There was a difference between treatments for the non-
cumulative water intake induced by acute injection of furosemide
[F (4, 30)=2.6; p=0.042]. LPS (0.3–5 mg/kg) reduced the water
intake by 30 to 80% at 15 min (Fig. 3, left). Therewas an effect for time
[F (4, 120)=72.4; pb0.001]. There was no interaction between
treatment and time [F (16, 120)=1.6; p=0.061].
There was a difference between treatments for the non-cumulative
water intake induced by gavage of 2 MNaCl [F (6, 18)=3.9; p=0.011].
LPS (0.3–5 mg/kg) reduced the water intake by 60 to 100% at 15 min
(Fig. 3, right). There was an effect for time [F (4, 12)=4.2; p=0.022].
Fig. 1. Non-cumulative 0.3 M NaCl (left) and water (right) intake of rats that received LPS or saline ip 1 h prior to FURO/CAP. N=7/group.
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pb0.001].3.4. Summary of the effects of LPS on ﬂuid intake
The results from Figs. 1 and 3 concerning water and 0.3 M NaCl
intake recorded at 15 min in all tests are summarized in Fig. 4. The
statistics are the same as that described for the original data from each
Figure valid only within and not between groups.
LPS abolished most of water intake induced by gavage at doses
(0.3, 0.6, 1.2 and 5 mg/kg) but reduced water intake induced byΔ 
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Fig. 2. Changes in mean arterial pressure (Δ MAP) and heart rate (Δ HR) of rats that
received LPS (0.6 mg/kg) or saline ip 1 h prior to FURO/CAP. Arrows indicate the
moments of injections. N=7/group.furosemide by only 40–80%. The same doses, excepting the highest,
barely had any effect on water intake induced by FURO/CAP, although
they were effective in abolishing 0.3 M NaCl intake induced by this
treatment.
3.5. Effects of LPS on renal excretion and blood biochemistry in rats
treated with FURO/CAP
LPS (0.6 mg/kg) reduced the diuresis and natriuresis by 30%
(pb0.05) relative to saline, without changing kaliuresis, in FURO/CAP
treated rats (Table 1). However, LPS had no effect on serum sodium or
potassium concentration, or on the total plasma protein concentration
of these animals (Table 1).
3.6. Effects of LPS on sodium excretion and blood biochemistry after NaCl
gavage
LPS (1.0 mg/kg) had no signiﬁcant effect on natriuresis, diuresis or
kaliuresis (Table 2). However, LPS reduced sodium urine concentra-
tion from 299±68 to 128±41 mEq/l (n=8 per group, p=0.049).
LPS reduced serum sodium and total serum protein concentration, but
had no effect on serum potassium concentration (Table 2).
4. Discussion
The lipopolysaccharide (LPS), at doses ranging from 0.3 to 5 mg/kg
ip inhibited 0.3 M NaCl intake induced by FURO/CAP treatment. The
same doses also reduced water intake induced by furosemide alone or
by an intragastric load of 2 M NaCl, while only the highest doses (2.5
and 5 mg/kg) inhibited water intake induced by FURO/CAP. LPS also
reduced urine volume and sodium excretion in rats treated with
FURO/CAP without changing their mean arterial pressure or heart
rate. LPS also reduced urine and serum sodium concentration and
total serum protein in rats that received 2 M NaCl by gavage. Only 2.5
and 5.0 mg/kg of LPS induced postural changes and hypothermia in
addition to reduction in ﬂuid intake.
The results suggest that LPS not only inhibits water intake, but also
inhibits sodium intake. However, a strong inhibitory effect on sodium
intake was achieved at low doses, whereas the maximum effect of LPS
on water intake was achieved only at the two highest doses. Thus, the
results also suggest that the inhibitory effect may be stronger on
sodium intake compared to water intake when the rat has the option
of ingesting sodium solution.
The effects of LPS on thirst were not exclusive for intracellular
dehydration as those of interleukin-1β given systemically [16]. The
effect of LPS on FURO/CAP- and furosemide-induced water intake is
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Fig. 3. Non-cumulative water intake of rats that received LPS or saline ip 1 h prior to 10 mg of furosemide ip (right) or prior to gavage of 2 M NaCl (left). N=4–8/group.
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angiotensin II [14,18,23–25]. However, doses of LPS that effectively
abolished gavage-induced thirst either had no effect or only partially
inhibited the FURO/CAP- or furosemide-induced thirst. The effect of
LPS also interacted with time when water intake was induced by
gavage. Thus, LPS can inhibit any kind of thirst, but the inhibition is
stronger on intracellular than extracellular thirst.
The inhibition LPS exerted on both types of thirst and on sodium
intake is consistent with the production of lethargy accompanied by
fever in the rat [27], but it also suggests that the inhibition is not of the
same degree for every behavior. Moreover, although LPS may elicit
central mechanisms to reduce activity and ingestive behavior [28], it
may also have a systemic effect, other than alteration in body
temperature or arterial pressure, which attenuated the signals of
dehydration and contributed to the inhibition of ﬂuid intake. The dose
of LPS that had no effect on body temperature or on arterial pressure
reduced both diuresis and natriuresis induced by furosemide in the
FURO/CAP tests, and reduced urine sodium concentration and serum
sodium concentration in the hypertonic NaCl gavage tests.
Although the effects of LPS on renal excretion may contribute to
the inhibition of ﬂuid intake, the 30% reduction induced by LPS on the
natriuresis induced by FURO/CAP does not correlate with the
complete suppression of sodium intake induced by the same dose of
LPS. This dissociation between the intensity of natriuresis and sodium
intake is consistent with previous ﬁndings showing that the amountFl
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Fig. 4. Summary of the effects of LPS on ﬂuid intake induced by different protocols at the
15 min of ingestive tests (FURO/CAP, furosemide or hypertonic NaCl gavage) according
to data withdrawn from Figs. 1 and 3. Signiﬁcance is based on SNK withdrawn from
two-way ANOVA performed for treatment, time and interaction between treatment
and time (see Figs. 1 and 3 for p values). Number of animals inside parentheses.of sodium ingested is higher than sodium loss when rats enter the
sodium appetite test 24 h after the injection of furosemide [29].
A decrease in MAP, concomitant with an increase in HR, occurred
in response to FURO/CAP as expected [18,25], whether the animals
were treated with LPS or not. A general inhibition of behavior was also
expected if LPS had debilitated the animal by producing a strong
hypotension associated with shock [4], but this did not happen in the
present experiments. Therefore, we cannot attribute the inhibition of
ﬂuid intake in FURO/CAP-treated animals to the cardiovascular effects
of LPS.
The LPS induced simultaneous reduction in serum sodium
concentration and total protein in animals that received the
hypertonic ig load. This suggests an expansion of blood volume and
dilution of the extracellular ﬂuid, which could generate inhibitory
signals for thirst [14]. Yet, the serum sodium concentration after LPS is
still ﬁve units above the range of normovolemic rats [21], which could
still contribute to cell dehydration [20]. Therefore, we cannot rule out
that the inhibition of intracellular thirst results from activation of
central mechanisms, systemic dilution and expansion of extracellular
ﬂuid, or a combination of central and systemic mechanisms.
The selective inhibition on intracellular thirst, reduced sodium
excretion and the expansion of blood volume is at least in part
consistent with a role to increase cardiovascular performance during
endotoxemia, as suggested in the Introduction [16]. However,
reduced sodium absorption in the intestine, as reported in previous
works [2], and the reduced sodium intake, as shown here, may have a
role to protect the animal from hypernatremia. This raises the
possibility that the central mechanisms that mediate LPS-induced
anorexia [28] overlap those that protect the rat from excess
hypertonic NaCl intake through the parabrachial and dorsal raphe
nucleus [30,31].
The results do not exclude the participation of interleukin-1β, but
they suggest that the effect of LPS on thirst is not mediated exclusively
by this type of interleukin. This is not surprising given the several
mediators activated by LPS. Recall, however, that icv injection ofTable 1
Renal excretion and blood biochemistry in rats treated with FURO/CAP combined with
saline or LPS (0.6 mg/kg).
Treatment UV
(ml/2 h)
UNaV
(μEq/2 h)
UKV
(μEq/2 h)
SNa
(mEq/l)
SK
(mEq/l)
Tp
(g/%)
LPS (8) 7.1±0.8* 831±10* 300±28 140±1 6.1±0.3 6.6±0.3
Saline (8) 10.3±0.2 1187±53 451±23 141±1 5.8±0.2 7.2±0.2
Values are means±S.E.M.; number of animals inside parentheses. UV, urine volume;
UNaV, amount of sodium excreted; UKV, amount of potassium excreted. SNa, serum
sodium concentration; SK, serum potassium concentration; TP, total serum protein.
* pb0.05 vs. Saline.
Table 2
Renal excretion and blood biochemistry of 2 M NaCl gavage-treated rats in response to
LPS (1 mg/kg).
Treatment UV
(ml/h)
UNaV
(μEq/h)
UKV
(μEq/h)
SNa
(mEq/l)
SK
(mEq/l)
Tp
(g/%)
LPS (8) 0.9±
0.3
183.6±
68.0
81.9±
32.9
141.6±
0.5*
4.8±
0.1
5.4±
0.1*
Saline (8) 0.8±
0.2
345.2±
146.7
72.6±
36.2
146.5±
0.6
4.9±
0.1
5.8±
0.1
Values are means±S.E.M.; number of animals inside parentheses. UV, urine volume;
UNaV, amount of sodium excreted; UKV, amount of potassium excreted. SNa, serum
sodium concentration; SK, serum potassium concentration; TP, total serum protein.
* pb0.05 vs. Saline.
169R.L. de Almeida et al. / Physiology & Behavior 102 (2011) 164–169interleukin-1β inhibits all types of thirst [32]. Moreover, LPS given
systemically also inhibits thirst induced by icv injections of either
angiotensin II or hypertonic NaCl [15]. Thus, it is possible that LPS
exerts its effects on thirst by separately affecting the systemic and
central production of interleukins.
In addition to the cytokines, the inhibitory effect of LPS on ﬂuid
intake could also result from the activation of inhibitory hormones
and neurotransmitters. LPS induces oxytocin secretion [4] dependent
on the activation of circumventricular organs and the hypothalamic
paraventricular nucleus [33]. The oxytocin secreted into the circula-
tion has been suggested as a marker for the activity of central
oxytocin, which may interact with α2-adrenoceptors to inhibit
sodium intake [34,35].
Reduced sodium excretion seems an initial response to LPS that
precedes renal failure in septicaemia or endotoxic shock [5,36].
However, one may speculate if reduced sodium excretion is adaptive
to milder infections by contributing to spare water and electrolytes
and thus compensate the predicted reduction in ﬂuid and mineral
intake. Accordingly, contrary to what was suggested in the Introduc-
tion, the effect on sodium excretion would be complemented by a
stronger inhibition of sodium compared to water intake, and by
preferential inhibition of intra- versus extracellular thirst. This
suggestion is analogous to the ability of the sick animal to reorganize
its selection of macronutrient intake according to its nutritional and
energetic requirements [1]. Therefore, it is possible that the effect of
LPS on sodium balance is an advantageous complement to the
strategy of sickness behavior.
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